SCHEMBL7515871

SCHEMBL7515871

CC=CCCNC(=O)OC(C)(C)C

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.51
CTSK P43235 2/20 0.49
MEN1 O00255 1/20 0.49
GAA P10253 1/20 0.49
KMT2A Q03164 1/20 0.49
MAOA P21397 1/20 0.45
MAOB P27338 1/20 0.45
CA1 P00915 6/20 0.43
CA2 P00918 6/20 0.43
CA12 O43570 4/20 0.43
CA9 Q16790 4/20 0.43
EPHX1 P07099 1/20 0.43
HTT P42858 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
CA7 P43166 1/20 0.39
ALDH1A1 P00352 1/20 0.38
GFER P55789 1/20 0.38
MALT1 Q9UDY8 1/20 0.38
IDO1 P14902 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22140598 1.00 TDP1 (0.51) TDP1CTSKMEN1GAAKMT2A
SCHEMBL23987947 1.00 TDP1 (0.51) TDP1CTSKMEN1GAAKMT2A
SCHEMBL13306408 0.90 TDP1 (0.56) TDP1CTSKMEN1GAAKMT2A
SCHEMBL20859578 0.86 TDP1 (0.63) TDP1CTSKMEN1GAAKMT2A
SCHEMBL8696113 0.86 TDP1 (0.63) TDP1CTSKMEN1GAAKMT2A
SCHEMBL25180911 0.85 TDP1 (0.55) TDP1CTSKMEN1GAAKMT2A
SCHEMBL590360 0.84 TDP1 (0.54) TDP1CTSKMEN1GAAKMT2A
SCHEMBL24197446 0.84 TDP1 (0.59) TDP1CTSKMEN1GAAKMT2A
SCHEMBL590359 0.84 TDP1 (0.54) TDP1CTSKMEN1GAAKMT2A
SCHEMBL18632637 0.84 TDP1 (0.50) TDP1CTSKMEN1GAAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105339355-B Novel CYP17 inhibitor/antiandrogen 奥赖恩公司 2018-02-27 CN disclosed
CN-105339355-A Novel CYP17 inhibitor/antiandrogen ORION CORP 2016-02-17 CN disclosed
EP-1185514-A1 PHARMACEUTICAL COMPOSITIONS AND METHODS FOR USE Targacept, Inc. (US) 2002-03-13 EP disclosed
EP-1171127-A2 PHARMACEUTICAL COMPOSITIONS CONTAINING PYRIDINE OR PYRIMIDINE DERIVATIVES FOR INHIBITION OF CYTOKINE PRODUCTION AND SECRETION Targacept, Inc. (US) 2002-01-16 EP disclosed
WO-2000075110-A1 PHARMACEUTICAL COMPOSITIONS AND METHODS FOR USE TARGACEPT, INC. (US) 2000-12-14 WO disclosed
WO-2000062767-A2 PHARMACEUTICAL COMPOSITIONS CONTAINING PYRIDINE OR PYRIMIDINE DERIVATES FOR INHIBITION OF CYTOKINE PRODUCTION AND SECRETION TARGACEPT, INC. (US) 2000-10-26 WO disclosed